Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124262) titled 'Multicenter prospective study on intermittent PegIFN a-2b therapy for chronic hepatitis B' on May 9.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: 920th Hospital of the Joint Logistics Support Force, PLA

Condition: Chronic hepatitis B

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-05-20

Target Sample Size: Early non-response group and early response group:300;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=315206

Published by HT Digital Content Services with permission from Health ...